Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative lidocaine infusion to prevent postoperative atrial fibrillation after cardiac surgery
ChiCTR2600129631Phase 2Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lidocaine in Atrial fibrillation (AFib) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Incidence of new-onset atrial fibrillation within 7 days after surgery. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2600129631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129631.